DMD and Duchenne muscular dystrophy: To verify the utility of LNP for DMD therapy, we formulated hEx45 sgRNA #1 and hEx45 sgRNA #23 into separate LNPs and evaluated the dystrophin restoration in myoblasts derived from DMD patient-induced pluripotent stem (iPS) cells.